Factor XI Variant Database

Case ID:
525
FXI:C% 40
FXI:Ag% 50
Reported Bleeding Severity (based on clinical description, not FXI:C assay) Asymptomatic
Comments on Case
Functional Analysis
Analysis Type
Reference Quelin et al 2009

The details of the variants found in this case are listed below


Variant ID No. of Cases Minor Allele Frequency Pathogenicity (ACMG)Definition Variant is: 1=Benign, 2=Likely Benign, 3=Unknown Significance (VUS), 4=Likely Pathogenic, 5=Pathogenic Comments on individual Variant Genotype of Variant Heterozygous Allele Common Variant Alleles (Legacy) Type Effect Location in gene Variant (cDNA) Variant (LRG) Variant (Genomic) Variant (Genomic HGVS) Codon Change Amino Acid No Protein Change Protein Domain
HGVS Legacy
333 7 TBA Recombinant variant poorly expressed: variant abolishes N-linked glycosylation site known to be utilised in vivo; however requirement appears to be for Thr (or Ser) but not for glycosylation Heterozygous Point Missense Exon 12 c.1478C>T LRG_583:g.24848C>T 24848C>T NG_008051.1:g.24848C>T ACA ATA 493 475 p.(Thr493Ile) Serine Protease